X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
asthma (49) 49
asthma - drug therapy (41) 41
hydrofluoroalkane-134a beclomethasone (39) 39
respiratory system (35) 35
administration, inhalation (32) 32
male (30) 30
adult (28) 28
female (26) 26
beclomethasone dipropionate (23) 23
index medicus (23) 23
fluticasone (22) 22
hydrofluoroalkane-134a beclomethasone dipropionate (22) 22
lung deposition (22) 22
inhaled corticosteroids (21) 21
middle aged (21) 21
particle size (21) 21
anti-asthmatic agents - administration & dosage (19) 19
allergy (18) 18
asthma - physiopathology (18) 18
beclomethasone - administration & dosage (18) 18
corticosteroids (18) 18
chlorofluorocarbon beclomethasone (17) 17
fluticasone propionate (17) 17
treatment outcome (16) 16
nebulizers and vaporizers (15) 15
immunology (14) 14
metered-dose inhaler (14) 14
small airways (14) 14
aged (13) 13
beclomethasone - therapeutic use (13) 13
steroids (13) 13
aerosols (12) 12
anti-asthmatic agents - therapeutic use (12) 12
child (12) 12
hydrofluoroalkane-134a (12) 12
adolescent (11) 11
adrenal cortex hormones - administration & dosage (11) 11
cardiac & cardiovascular systems (10) 10
double-blind method (10) 10
efficacy (10) 10
metered dose inhalers (10) 10
aerosol propellants (9) 9
antiasthmatic agents (9) 9
approximately half (9) 9
bronchodilator agents - administration & dosage (9) 9
budesonide (9) 9
chlorofluorocarbons (9) 9
dose-response relationship, drug (9) 9
drug dosages (9) 9
hydrocarbons, fluorinated (9) 9
pharmacokinetics (9) 9
chlorofluorocarbon (8) 8
drug therapy (8) 8
glucocorticoids - administration & dosage (8) 8
inflammation (8) 8
pharmacology & pharmacy (8) 8
aged, 80 and over (7) 7
analysis (7) 7
copd (7) 7
critical care medicine (7) 7
dosage and administration (7) 7
double-blind (7) 7
drug combinations (7) 7
extrafine aerosol (7) 7
lung - drug effects (7) 7
lung - physiopathology (7) 7
obstructive pulmonary-disease (7) 7
salmeterol (7) 7
young adult (7) 7
aerosol (6) 6
androstadienes - administration & dosage (6) 6
anti-asthmatic agents - adverse effects (6) 6
asthma control (6) 6
care and treatment (6) 6
chlorofluorocarbon fluticasone (6) 6
deposition (6) 6
hfa-beclomethasone (6) 6
persistent asthma (6) 6
pulmonary and respiratory medicine (6) 6
pulmonary disease, chronic obstructive - drug therapy (6) 6
safety (6) 6
adrenal cortex hormones - adverse effects (5) 5
alveolar nitric-oxide (5) 5
androstadienes - adverse effects (5) 5
androstadienes - therapeutic use (5) 5
asthma - diagnosis (5) 5
chemistry, pharmaceutical (5) 5
childhood asthma (5) 5
chlorofluorocarbon beclomethasone dipropionate (5) 5
chronic obstructive pulmonary disease (5) 5
clinical trials as topic (5) 5
drug administration schedule (5) 5
dry powder inhaler (5) 5
forced expiratory volume - drug effects (5) 5
lung - metabolism (5) 5
particle-size (5) 5
patients (5) 5
pulmonary/respiratory (5) 5
quality of life (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia,... 
APPROXIMATELY HALF | RECEPTOR NUCLEAR TRANSLOCATION | SALMETEROL/FLUTICASONE PROPIONATE | THERAPY GUIDELINES | EXACERBATIONS | ASTHMA | PULMONARY-DISEASE | COPD PATIENTS | HYDROFLUOROALKANE-134A BECLOMETHASONE DIPROPIONATE | SALMETEROL
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2009, Volume 22, Issue 4, pp. 326 - 332
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 132, Issue 1, pp. 45 - 54.e10
Journal Article
Chest, ISSN 0012-3692, 02/1999, Volume 115, Issue 2, pp. 343 - 351
The improved lung deposition of hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) extrafine aerosol compared with chlorofluorocarbon beclomethasone... 
chlorofluorocarbon beclomethasone dipropionate | hydrofluoroalkane-134a beclomethasone dipropionate | moderate asthma | Moderate asthma | Chlorofluorocarbon beclomethasone dipropionate | Hydrofluoroalkane-134a beclomethasone dipropionate
Journal Article
Chest, ISSN 0012-3692, 06/2017, Volume 151, Issue 6, pp. 1345 - 1355
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 6, p. e0178112
Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia, particularly in... 
APPROXIMATELY HALF | RECEPTOR NUCLEAR TRANSLOCATION | MULTIDISCIPLINARY SCIENCES | SALMETEROL/FLUTICASONE PROPIONATE | THERAPY GUIDELINES | EXACERBATIONS | ASTHMA | PULMONARY-DISEASE | HYDROFLUOROALKANE-134A BECLOMETHASONE DIPROPIONATE | COPD | SALMETEROL | Bronchodilator Agents - administration & dosage | Pneumonia - epidemiology | Humans | Middle Aged | Administration, Inhalation | Logistic Models | Male | Pharmacovigilance | Pulmonary Disease, Chronic Obstructive - complications | Dose-Response Relationship, Drug | Particle Size | Young Adult | Adrenal Cortex Hormones - adverse effects | Pneumonia - chemically induced | Adolescent | Aged, 80 and over | Adult | Female | Aged | Bronchodilator Agents - adverse effects | Child | United Kingdom - epidemiology | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Care and treatment | Pneumonia | Corticosteroids | Bacterial pneumonia | Dosage and administration | Research | Diagnosis | Health aspects | Risk factors | Corticoids | Particle size | Risk | Fluticasone | Data bases | Streptococcus infections | Ethics | Databases | Chronic obstructive pulmonary disease | Respiratory therapy | Medical research | Adjustment | Lung diseases | Propionic acid | Regression analysis | Patients | Quality of life | Asthma | Diseases | Hospitals | Equivalence | Obstructive lung disease | Stepped | Models | Health risk assessment | Steroids
Journal Article
Journal Article
Clinics in Chest Medicine, ISSN 0272-5231, 06/2008, Volume 29, Issue 2, pp. 277 - 296
Pressurized metered-dose inhalers (pMDIs) and nebulizers are employed routinely for aerosol delivery to ventilator-supported patients, but the ventilator... 
METERED-DOSE INHALER | OBSTRUCTIVE PULMONARY-DISEASE | IN-VITRO | LUNG MODEL | HYDROFLUOROALKANE-134A HFA ALBUTEROL | BRONCHODILATOR DELIVERY | RESPIRATORY SYSTEM | HELIUM-OXYGEN | TO-MODERATE ASTHMATICS | COPD PATIENTS | RESPIRATORY-DISTRESS-SYNDROME | Aerosols | Respiration, Artificial | Humans | Nebulizers and Vaporizers
Journal Article
Journal Article